Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea... Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 9.86 | 24.1963190184 | 40.75 | 61.07 | 15.3 | 1612200 | 48.96069558 | CS |
4 | 2.55 | 5.30586766542 | 48.06 | 61.07 | 15.3 | 585784 | 47.72393463 | CS |
12 | 2.62 | 5.45947072307 | 47.99 | 61.07 | 15.3 | 255370 | 47.45655074 | CS |
26 | 34.41 | 212.407407407 | 16.2 | 61.07 | 15.3 | 166766 | 41.89972012 | CS |
52 | 33.71 | 199.467455621 | 16.9 | 61.07 | 15.0001 | 140367 | 40.80080186 | CS |
156 | 33.71 | 199.467455621 | 16.9 | 61.07 | 15.0001 | 140367 | 40.80080186 | CS |
260 | 33.71 | 199.467455621 | 16.9 | 61.07 | 15.0001 | 140367 | 40.80080186 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관